Cargando cotizaciones...
Previsión
No hay datos de analistas disponibles para esta empresa.
Noticias Ir al feed de noticias
Growthpoint raises dividend for 2026, warns of weaker growth in 2027
Growthpoint increased distributable earnings per share by 4.3% to 152.6 cents and raised the dividend for 2026 by 7.4% to 133 cents. Net asset value per share rose by 3.8%, the loan-to-value ratio improved to 38.7%; net rental income in South Africa grew like-for-like by 4.4%. For 2027 management now forecasts only 1–3% dividend growth, citing the weak office market in Gauteng, slower reinvestment after disposals and higher financing costs as headwinds. » Más en de.investing.com
Growthpoint sells entire 14.2% stake in NewRiver REIT for £50.5 million
Growthpoint Properties Limited has completed the sale of its entire 14.2% stake in NewRiver REIT plc, disposing of 67.4 million ordinary shares at 75 pence each for gross proceeds of £50.5 million. The placing was conducted, according to the announcement, with strong interest from existing and new investors; Panmure Liberum Limited acted as sole bookrunner and settlement is scheduled for 15 August 2025. NewRiver REIT itself will receive no proceeds from the transaction, as it was a sale of Growthpoint’s existing shares. » Más en de.investing.com
Growthpoint plans sale of around 47.7 million NewRiver shares at 75p each
Growthpoint Properties Limited will sell approximately 47.7 million ordinary shares of NewRiver REIT plc in an accelerated bookbuild at 75 pence per share, representing most of its previous 14.2% holding. NewRiver has said it intends to buy back up to around 47.7 million of the placed shares; Panmure Liberum is sole bookrunner and NewRiver will receive no proceeds from the secondary placing. The announcement was published as inside information under the UK Market Abuse Regulations, and the final placing result will be announced after the bookbuild is complete. » Más en de.investing.com
Dividendos históricos Dividendos
Todas las métricas de dividendos Todas las métricasDatos financieros de la empresa
| (EUR) | junio de 2026 | YoY |
|---|---|---|
| Ingresos | 327,8 M | - |
| Beneficio bruto | 181,17 M | - |
| Beneficio neto | 275,82 M | - |
| EBITDA | 451,16 M | - |
Datos fundamentales
| Métrica | Valor |
|---|---|
Capitalización bursátil | 3015,1 M € |
Número de acciones | 33,86 M |
Máximo/mínimo de 52 semanas | 103,21 € - 82,79 € |
Rentabilidad por dividendo | 7,96 % |
Dividendos TTM | 0,0709 € |
Beta | 0,59 |
Ratio P/E | 7,35 |
Ratio PEG | 0,17 |
Ratio P/B | 0,79 |
Ratio P/S | 4,31 |
Perfil de la empresa
Growthpoint es el mayor REIT primario sudafricano cotizado en la JSE, con una cartera de calidad de 440 propiedades de su propiedad directa en Sudáfrica (RSA) valoradas en R73.400 millones, incluidos cuatro hospitales y un centro médico valorados en R2.600 millones, propiedad de Growthpoint Healthcare Property Holdings (RF) Limited (GHPH). Growthpoint tiene una participación accionarial del 61,8% en GHPH. Tenemos una participación del 62,2% en Growthpoint Properties Australia Limited (GOZ), cotizada en la ASX, que posee 58 propiedades en Australia valoradas en R51.800 millones, y una participación del 52,1% en Capital & Regional Plc (C&R), cotizada en la LSE, que posee siete propiedades en el Reino Unido valoradas en R14.800 millones.
| Nombre | GROWTHPOINT PPTYS |
| CEO | Estienne Konrad de Klerk |
| Sede | Sandton,
gp Sudáfrica |
| Sitio web | |
| Salida a bolsa | 11/04/2018 |
| Empleados | 634 |
Deep Dive
Símbolos bursátiles
| Bolsa | Símbolo |
|---|---|
Jnb | GRT.JO |
Pnk | GWWTF |
Frankfurt | G5JA.F |
München | G5JA.MU |